Eisler Capital (UK)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.62M Buy
5,030
+1,155
+30% +$617K 0.01% 422
2024
Q2
$2.1M Buy
3,875
+1,043
+37% +$551K 0.01% 402
2024
Q1
$1.47M Buy
+2,832
New +$1.41M 0.01% 476

Other funds holding ELV

Eisler Capital (UK)'s ELV Position: Q3 2024 in Review

Eisler Capital (UK) increased its Elevance Health (ELV) stake by 30% in Q3 2024, buying an estimated $617K and bringing the position to 5,030 shares worth $2.62M. The position accounts for 0.01% of the portfolio, ranked #422.

Eisler Capital (UK) first reported a position in ELV in Q1 2024 and has held it in 3 quarters since. 1,694 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Eisler Capital (UK) held 5,030 shares of Elevance Health worth $2.62M as of Q3 2024.
  • Eisler Capital (UK) bought 1,155 Elevance Health shares in Q3 2024, an estimated $617K.
  • Elevance Health made up 0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #422 holding.
  • Eisler Capital (UK) first reported a position in Elevance Health in Q1 2024 and has held it in 3 quarters since.
  • 1,694 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.